Media Centre
Latest press releases
-
Klygefa (gefurulimab) approved in the US for the treatment of generalised myasthenia gravis (gMG) in adult patients
-
Klygefa (gefurulimab) approved in the EU for the treatment of adults with generalised myasthenia gravis (gMG)
-
Perioperative Imfinzi approved in the US in novel regimen with neoadjuvant enfortumab vedotin for patients with muscle-invasive bladder cancer
-
Baxfendy (baxdrostat) recommended for approval in the EU for the treatment of adults with hypertension
-
9M and Q3 2026 results
-
Enhertu approved in the EU as adjuvant treatment for patients with residual disease after neoadjuvant treatment for HER2-positive early breast cancer
Medical Releases
These press releases are specifically for health specialist/medical media and are not for consumer press.